Written by James C. Morton Jr., Staff Writer. In a randomized placebo-controlled, double-blinded, clinical trial research study, Hibiscus Sabdariffa significantly decreased systolic blood pressure (5.5%) and diastolic blood pressure (4.0%) compared to the baseline and placebo groups.  

hibiscusHypertension is one of the most common causes of cardiovascular disease, in addition to renal failure and atherosclerosis. It is characterized by the arterial blood pressure reaching over 120 mmHg for systolic and 80 mmHg for diastolic measures. Blood pressure is determined by the amount of blood the heart pumps and the amount of resistance to blood flow in the arteries 1. In the United States, it’s estimated about 80 million Americans (1 in 3 adults) have high blood pressure, and in 2014 it was the leading contributor to the cause of death for 410,000 people 2. Deaths from diseases such as cardiovascular disease, stroke and atherosclerosis are directly associated with hypertension. It is medically known as the “silent killer” because 20% of the population don’t know that they have hypertension. The latest statistics for hypertension health care cost is $48.6 billion per year 3.

The most popular treatment approach for hypertensive patients is the use of prescription medication. These chemical medications block or inhibit biological pathways that cause vascular constriction, while other medications cause blood vessels to dilate, which decreases arterial blood pressure 4. Unfortunately, patients may have to be treated on medication for many years 5.

Fortunately, a 2009 study (6) reveals that Hibiscus sabdariffa L. tea reduces hypertensive symptoms. The study involved 65 patients (37 men, and 28 women) aged 30 to 70 with pre-and mildly hypertension (systolic > 120 to 150 mm Hg, diastolic > 80 to 95 mm Hg). They were given either 720 milligrams a day of Hibiscus sabdariffa or a placebo for 6 weeks. Before and after the study, systolic and diastolic blood pressure was measured to minimize bias 6,7.

After 6 weeks, the researchers noted the following results for Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), and Means (average) Arterial Pressure (MAP). p-value 0.05 = significant.

Hibiscus TeaPlacebo
SBP, mm Hg5.5% Decrease (from 129.4 to 122.3)
p = 0.001, Significant
.92% Decrease (from 129.8 to 128.6)
p = 0.30, Not Significant
DBP, mm Hg4.0% Decrease (from 78.9 to 75.8)
p = 0.002, Significant
.75% Decrease (from 79.6 to 79.0)
p = 0.40, Not Significant
MAP, mm Hg4.7 % Decrease (from 95.7 to 91.3)
p = 0.002, Significant
.85% Decrease (from 96.3 to 95.5)
p = 0.30, Not Significant

In addition, the researchers noted that the blood pressure measurements were taken prior to the participants having breakfast to establish a 12-hour fasting to determine the effects of drinking hibiscus tea.

When suggesting how Hibiscus sabdariffa benefits those with hypertension, the researchers pointed to H. sabdariffa’s strong ability to absorb oxygen radicals 8,9, the capacity of its antioxidant flavonoids to decrease the risk of heart disease 10,11, and its anthocyanin and polyphenols levels that increase nitric oxide production to relax the blood vessels and help prevent plaque build-up in the arteries 12. The researchers noted that other studies revealed how Hibiscus tea benefited patients with type-ll diabetes and hypertension, due to its anti-inflammatory properties. Limitations of the study include its sample size and duration time, and the inability to analyze anthocyanin in the plasma and urine. H. sabdariffa should be evaluated in a larger population to fully validate how it can help manage and prevent hypertension.

Source:  Diane L. McKay, C-Y. Oliver Chen, Edward Saltzman, and Jeffrey B. Blumberg. Hibiscus Sabdariffa L. Tea (Tisane) Reduces Blood Pressure in Pre-and Mildly Hypertensive Patients. American Society for Nutrition 2010; doi:10.3945/jn.109.115097.

© American Society for Nutrition

Click here to read the full text study.

Posted January 5, 2017.

References:

  1. Mayoclinic.org. High blood pressure (hypertension). http://www.mayoclinic.org/diseases-conditions/high-blood-pressure/basics/definition/con-20019580. Accessed December 21, 2016.
  2. Association AH. High Blood Pressure or Hypertension. 2016.
  3. CDC. High Blood Pressure Fact Sheet.
  4. Prevention CfDCa. Recent Trends in the Prevalence of High Blood Pressure and its Treatment and Control, 1999-2008. https://www.cdc.gov/nchs/data/databriefs/db48.htm. Accessed December 30, 2016, 2016.
  5. Medicine HH. Hypertension Center Overview. http://www.hopkinsmedicine.org/gim/clinical/hypertension/. Accessed December 21, 2016.
  6. McKay DL, Chen CO, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. The Journal of nutrition. 2010;140(2):298-303.
  7. Chobanian A. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
  8. Frank T, Janßen M, Netzel M, et al. Pharmacokinetics of Anthocyanidin‐3‐Glycosides Following Consumption of Hibiscus sabdariffa L. Extract. The Journal of Clinical Pharmacology. 2005;45(2):203-210.
  9. Salleh MN, Runnie I, Roach PD, Mohamed S, Abeywardena MY. Inhibition of low-density lipoprotein oxidation and up-regulation of low-density lipoprotein receptor in HepG2 cells by tropical plant extracts. Journal of Agricultural and Food Chemistry. 2002;50(13):3693-3697.
  10. Tsai P-J, McIntosh J, Pearce P, Camden B, Jordan BR. Anthocyanin and antioxidant capacity in Roselle (Hibiscus sabdariffa L.) extract. Food Research International. 2002;35(4):351-356.
  11. Fuleki T, Francis F. Determination of total anthocyanin and degradation index for cranberry juice. Food Science. 1968;33(1):78-83.
  12. Xu J-W, Ikeda K, Yamori Y. Upregulation of endothelial nitric oxide synthase by cyanidin-3-glucoside, a typical anthocyanin pigment. Hypertension. 2004;44(2):217-222.